comprehensive -WSS

comprehensive

author：Wikipedia 2025-08-26 01:32:36 - browse：7

A stethoscope lays on banknotes next to a calculator, all on top of a insurance application form — coverage from STAT — Adobe

Major insurance companies like UnitedHealthcare and Humana have edged out private equity firms from investing in Medicare Advantage, according to a new report.

But investors have found pockets of profits by backing companies involved in enrolling seniors in MA plans and keeping track of them once they’re there. They’re investing in insurance brokerages, marketers, in-home assessment companies, and “insurtechs,” the report said, based on a new analysis of deals in the space since 2016.

Overall, private equity investors made only 4 investments in Medicare Advantage-related companies last year, compared with 12 in 2022, down from a peak of 19 in 2021, per the Private Equity Stakeholder Project, a group focused on holding private equity firms accountable for their impacts on people and the planet, according to its website.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： The inclusion problem at the heart of rehabilitation research

hotspot

WSS

What causes osteoarthritis? Researchers study link to brain protein

FDA endorses new sterilization method for medical devices

Cytokinetics sells Royalty Pharma a share of its heart drug for up to $575M

Questions and answers about ramping up H5N1 bird flu vaccine

Making the case for fair compensation in clinical trials

Eyeing GLP

Wikipedia

comprehensive

explore

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

A pediatrician calls for Congress to pass the child tax credit deal

What does generative AI mean for health care? We asked experts

Listen: A conversation with researcher Kevin Esvelt on biosecurity

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Listen: A conversation with researcher Kevin Esvelt on biosecurity

After affirmative action ruling, medical educators look to 'holistic review'

Questions and answers about ramping up H5N1 bird flu vaccine

Virginia high school admissions case could be legal follow

Cue Health, Covid

entertainment

Dog Aging Project founders on what lies ahead after losing funding

The inclusion problem at the heart of rehabilitation research

HPV vaccine, cervical cancer study delivers historic results

To bolster infectious disease surveillance, genomics powerhouses team up

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

Eyeing GLP

hotspot

focus

leisure time

hotspot